Literature DB >> 27477966

SAGE committee advice on dengue vaccine.

Tikki Pang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27477966     DOI： 10.1016/S1473-3099(16)30167-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  10 in total

1.  Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity.

Authors:  Matthew Dent; Jonathan Hurtado; Amber M Paul; Haiyan Sun; Huafang Lai; Ming Yang; Adrian Esqueda; Fengwei Bai; Herta Steinkellner; Qiang Chen
Journal:  J Gen Virol       Date:  2016-10-20       Impact factor: 3.891

2.  The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.

Authors:  Stefan Flasche; Mark Jit; Isabel Rodríguez-Barraquer; Laurent Coudeville; Mario Recker; Katia Koelle; George Milne; Thomas J Hladish; T Alex Perkins; Derek A T Cummings; Ilaria Dorigatti; Daniel J Laydon; Guido España; Joel Kelso; Ira Longini; Jose Lourenco; Carl A B Pearson; Robert C Reiner; Luis Mier-Y-Terán-Romero; Kirsten Vannice; Neil Ferguson
Journal:  PLoS Med       Date:  2016-11-29       Impact factor: 11.069

3.  The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits.

Authors:  Jacqueline Deen
Journal:  PLoS Med       Date:  2016-11-29       Impact factor: 11.069

4.  The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries.

Authors:  Maíra Aguiar; Nico Stollenwerk; Scott B Halstead
Journal:  PLoS Negl Trop Dis       Date:  2016-12-21

Review 5.  Development of Antibody Therapeutics against Flaviviruses.

Authors:  Haiyan Sun; Qiang Chen; Huafang Lai
Journal:  Int J Mol Sci       Date:  2017-12-25       Impact factor: 5.923

6.  An economic evaluation of vector control in the age of a dengue vaccine.

Authors:  Christopher Fitzpatrick; Alexander Haines; Mathieu Bangert; Andrew Farlow; Janet Hemingway; Raman Velayudhan
Journal:  PLoS Negl Trop Dis       Date:  2017-08-14

Review 7.  Ancient oncogenesis, infection and human evolution.

Authors:  Riaan F Rifkin; Marnie Potgieter; Jean-Baptiste Ramond; Don A Cowan
Journal:  Evol Appl       Date:  2017-07-11       Impact factor: 5.183

8.  Projected costs associated with school-based screening to inform deployment of Dengvaxia: Vietnam as a case study.

Authors:  Hugo C Turner; Bridget A Wills; Motiur Rahman; Hoang Quoc Cuong; Guy E Thwaites; Maciej F Boni; Hannah E Clapham
Journal:  Trans R Soc Trop Med Hyg       Date:  2018-08-01       Impact factor: 2.184

9.  Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM).

Authors:  Camilly P Pires de Mello; George L Drusano; Jaime L Rodriquez; Ajeet Kaushik; Ashley N Brown
Journal:  Viruses       Date:  2018-06-09       Impact factor: 5.048

Review 10.  Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.

Authors:  Mohd Ishtiaq Anasir; Babu Ramanathan; Chit Laa Poh
Journal:  Viruses       Date:  2020-03-26       Impact factor: 5.048
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.